Department of Radiology, Breast Imaging Section, University of Washington Medical Center, University of Washington School of Medicine, Seattle, WA, USA.
AJR Am J Roentgenol. 2011 Jan;196(1):W93-9. doi: 10.2214/AJR.10.4804.
The purpose of our study is to report the outcomes at a center that routinely uses breast MRI for preoperative staging, regardless of lesion histology or patient characteristics.
Five hundred ninety-two patients with recently diagnosed breast cancer who underwent staging with preoperative breast MRI between January 1, 2003, and April 30, 2007, were reviewed. Five hundred seventy patients comprised the analysis set. Patient age, breast density, index tumor histology, receptor status (ER, PR, and HER2), and lymph node status were recorded. Biopsy rates, positive predictive values (PPVs) of biopsy, and overall cancer yield were calculated and compared using the chi-square test across patient age, mammographic breast density, index tumor type, receptor status, and lymph node status.
Biopsy was recommended and performed for 152 of 570 (27%) patients found to have one or more suspicious lesions on MRI distinct from the index cancer. Sixty-seven of 152 women who underwent biopsy had additional cancers diagnosed, for a PPV of 44%. Overall, 12% (67/570) of women had otherwise occult cancers diagnosed by MRI, with 8% having additional sites or greater extent of ipsilateral disease and 4% having unsuspected contralateral cancer detected by MRI alone. No significant differences were found in the probability of detecting an occult cancer on the basis of patient age, breast density, index tumor characteristics, or lymph node status.
Breast MRI detects otherwise occult cancer with an overall added cancer yield of 12% and a high PPV of 44% when applied to a diverse population of patients with newly diagnosed breast cancer.
本研究旨在报告一个中心的结果,该中心常规使用乳腺 MRI 进行术前分期,无论病变组织学或患者特征如何。
回顾了 2003 年 1 月 1 日至 2007 年 4 月 30 日期间接受术前乳腺 MRI 分期的 592 例新近诊断为乳腺癌的患者。570 例患者构成了分析集。记录了患者年龄、乳腺密度、指数肿瘤组织学、受体状态(ER、PR 和 HER2)和淋巴结状态。使用卡方检验比较了患者年龄、乳腺 X 线摄影密度、指数肿瘤类型、受体状态和淋巴结状态在活检率、活检的阳性预测值 (PPV) 和总癌症检出率方面的差异。
在 570 例 MRI 上发现一个或多个与指数癌症不同的可疑病变的患者中,有 152 例推荐并进行了活检。在接受活检的 152 名女性中,有 67 名被诊断出患有额外的癌症,PPV 为 44%。总体而言,12%(67/570)的女性通过 MRI 诊断出隐匿性癌症,其中 8%有更多部位或同侧疾病的更大程度受累,4%通过 MRI 单独发现了意外的对侧癌症。在基于患者年龄、乳腺密度、指数肿瘤特征或淋巴结状态检测隐匿性癌症的概率方面,未发现显著差异。
当应用于新诊断乳腺癌的不同患者人群时,乳腺 MRI 总体上可检测出 12%的隐匿性癌症,并且具有 44%的高 PPV。